晚期卵巢癌长期生存者的复发恐惧、情绪健康与生活质量
58例晚期上皮性卵巢癌长期生存者完成标准化问卷,评估生活质量与复发恐惧。平均诊断年龄52.8岁,平均生存13.5年,64%有复发。生活质量优于美国健康女性常模,但27%报告高复发恐惧,且复发恐惧与情绪健康呈负相关,在复发患者中影响更大。
要点
- 晚期卵巢癌长期生存者生活质量优于美国健康女性常模(FACT-G T评分55.9)。
- 27%的长期生存者报告高复发恐惧,复发恐惧与情绪健康呈负相关(p<0.001)。
- 复发与复发恐惧存在显著交互作用(p=0.034),复发患者中复发恐惧对情绪健康影响更大。
核心结论
- 晚期卵巢癌长期生存者的生活质量优于美国健康女性平均水平,但高复发恐惧显著增加情绪困扰,在复发患者中尤为明显。
- 作者认为在这一生存者群体中关注复发恐惧可能是必要的。
研究设计与样本
- 58例晚期上皮性卵巢癌长期生存者参与研究,完成标准化问卷以采集癌症病史、生活质量和复发恐惧,统计分析采用多变量线性模型。
主要发现
- 参与者诊断时平均年龄52.8岁,生存时间超过8年(平均13.5年),64%有复发疾病。
- FACT-G、FACT-O和FACT-O-TOI平均分分别为90.7(SD 11.6)、128.6(SD 14.8)和85.9(SD 10.2)。
- 以T评分与美国人群比较,参与者生活质量超过健康成年人(FACT-G T评分55.9)。
- 复发患者总体生活质量低于无复发患者,但差异未达统计学显著(FACT-O 126.1 vs 133.3,p=0.082)。
- 尽管生活质量良好,27%报告高复发恐惧;复发恐惧与情绪健康呈负相关(p<0.001),与其他生活质量子领域无关。
临床怎么用
- 作者认为在这一生存者群体中关注复发恐惧可能是必要的。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although advanced stage epithelial ovarian cancer is widely considered life-threatening, 17% of women with advanced disease will survive long-term. Little is known about the health-related quality of life (QOL) of long-term ovarian cancer survivors, or how fear of recurrence might affect QOL. METHODS: 58 long-term survivors with advanced disease participated in the study. Participants completed standardized questionnaires to capture cancer history, QOL, and fear of recurrent disease (FOR). Statistical analyses included multivariable linear models. RESULTS: Participants averaged 52.8 years at diagnosis and had survived >8 years (mean:13.5); 64% had recurrent disease. Mean FACT-G, FACT-O, and FACT-O-TOI (TOI) scores were 90.7 (SD:11.6), 128.6 (SD:14.8), and 85.9 (SD:10.2) respectively. Compared to the U.S. population using T-scores, QOL for participants exceeded that of healthy adults (T-score (FACT-G) = 55.9). Overall QOL was lower in women with recurrent vs. non-recurrent disease though differences did not reach statistical significance (FACT-O = 126.1 vs. 133.3, p = 0.082). Despite good QOL, high FOR was reported in 27%. FOR was inversely associated with emotional well-being (EWB) (p < 0.001), but not associated with other QOL subdomains. In multivariable analysis, FOR was a significant predictor of EWB after adjusting for QOL (TOI). A significant interaction was observed between recurrence and FOR (p = 0.034), supporting a larger impact of FOR in recurrent disease. CONCLUSION: QOL in long-term ovarian cancer survivors was better than the average for healthy U.S. women. Despite good QOL, high FOR contributed significantly to increased emotional distress, most notably for those with recurrence. Attention to FOR may be warranted in this survivor population.
引用
- Osann K, Wenzel L, McKinney C, et al. Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors. Gynecol Oncol. 2023. PMID: 36905875. doi:10.1016/j.ygyno.2023.02.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。